FIELD: otolaryngology. SUBSTANCE: interferon and immunologic status of patients are determined and, according to character of deviations found, correction with recombinant interferons and interferon inductors during pre- and postoperative periods is performed both in combination and as monotherapy. EFFECT: enhanced treatment efficiency. 2 cl, 2 ex
Authors
Dates
1999-10-27—Published
1998-11-03—Filed